학술논문

Plasma Soluble Tumor Necrosis Factor Receptor Concentrations and Clinical Events After Hospitalization: Findings From the ASSESS-AKI and ARID Studies
Document Type
Article
Source
American Journal of Kidney Diseases; February 2023, Vol. 81 Issue: 2 p190-200, 11p
Subject
Language
ISSN
02726386; 15236838
Abstract
The role of plasma soluble tumor necrosis factor receptor 1 (sTNFR1) and sTNFR2 in the prognosis of clinical events after hospitalization with or without acute kidney injury (AKI) is unknown.